Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (August 8, 2003). doi:10.1152/japplphysiol.00404.2003
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
95/6/2563    most recent
00404.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Przyklenk, K.
Right arrow Articles by Kloner, R. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Przyklenk, K.
Right arrow Articles by Kloner, R. A
Submitted on April 23, 2003
Accepted on August 4, 2003

Mechanisms of Myocardial Ischemic Preconditioning are Age-Related: Protein Kinase C-{epsilon} Does Not Play a Requisite Role in Old Rabbits

Karin Przyklenk1*, Guohu Li2, Boris Z Simkhovich3, and Robert A Kloner3

1 Department of Emergency Medicine and Anesthesiology, University of Massachusetts Medical School, Worcester, MA, USA; Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA; Department of Medicine, Section of Cardiology, University of Southern California, Los Angeles, CA, USA
2 Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA
3 Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA; Department of Medicine, Section of Cardiology, University of Southern California, Los Angeles, CA, USA

* To whom correspondence should be addressed. E-mail: Karin.Przyklenk{at}umassmed.edu.

Data obtained from adult cohorts has implicated activation/translocation of protein kinase C (PKC)-{epsilon} as an important cellular mediator of myocardial infarct size reduction with ischemic preconditioning (PC). Age-related alterations in cellular signaling may, however, confound the extrapolation of mechanistic insight derived from adults to the aging population -- the specific subset in which cardioprotection is undoubtedly most relevant. Accordingly, our aim was to investigate the role of PKC{epsilon} as a mediator of infarct size reduction with preconditioning in old versus adult rabbits. In Protocol 1, we assessed the effect of PKC{epsilon} translocation inhibitor peptide (PKC{epsilon}-TIP) and the pan-PKC inhibitor chelerythrine on infarct size reduction with PC in adult and ~4 year old rabbits, a population previously shown to exhibit definitive hallmarks of cardiovascular aging. Rabbits received 5 min of PC ischemia or a matched control period followed by 30 min of coronary artery occlusion and 3 h of reperfusion, with infarct size (delineated by tetrazolium staining) serving as the primary endpoint. In Protocol 2, we obtained preliminary insight (by Western immunoblotting) into the subcellular redistribution of PKC{epsilon} in response to the 5 min PC stimulus in adult and old rabbits. In adults, infarct size reduction with PC was abrogated by both PKC{epsilon}-TIP and chelerythrine. However, in old rabbits: (i) PC-induced cardioprotection was maintained despite inhibitor treatment; and (ii) brief PC ischemia was not associated with activation/translocation of PKC{epsilon}. Thus, the mechanisms responsible for PC are age-related in rabbit heart, with no apparent, requisite role of PKC{epsilon} in aging animals.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Xue and L. Zhang
Prenatal Hypoxia Causes a Sex-Dependent Increase in Heart Susceptibility to Ischemia and Reperfusion Injury in Adult Male Offspring: Role of Protein Kinase C{epsilon}
J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 624 - 632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and J. P. Headrick
Clinical cardioprotection and the value of conditioning responses
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1705 - H1720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Meyer, H. Zhang, and L. Zhang
Prenatal cocaine exposure abolished ischemic preconditioning-induced protection in adult male rat hearts: role of PKC{varepsilon}
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1566 - H1576.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Dow, A. Bhandari, and R. A. Kloner
Ischemic Postconditioning's Benefit on Reperfusion Ventricular Arrhythmias Is Maintained in the Senescent Heart
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 141 - 148.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Przyklenk, M. Maynard, and P. Whittaker
Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial KATP channels
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H830 - H836.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Bae and L. Zhang
Gender Differences in Cardioprotection against Ischemia/Reperfusion Injury in Adult Rat Hearts: Focus on Akt and Protein Kinase C Signaling
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1125 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
G. Kristo, Y. Yoshimura, B. J. Keith, R. M. Mentzer Jr., and R. D. Lasley
Aged Rat Myocardium Exhibits Normal Adenosine Receptor-Mediated Bradycardia and Coronary Vasodilation But Increased Adenosine Agonist-Mediated Cardioprotection
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1399 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Willems, K. J. Ashton, and J. P. Headrick
Adenosine-mediated cardioprotection in the aging myocardium
Cardiovasc Res, May 1, 2005; 66(2): 245 - 255.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ikeda, H. Kobayashi, and K. Shimamoto
Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection
Cardiovasc Res, February 15, 2004; 61(3): 610 - 619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1966 by the American Physiological Society.